Jasper Therapeutics Balance Sheet Health
Financial Health criteria checks 6/6
Jasper Therapeutics has a total shareholder equity of $83.7M and total debt of $0.0, which brings its debt-to-equity ratio to 0%. Its total assets and total liabilities are $99.4M and $15.7M respectively.
Key information
0%
Debt to equity ratio
US$0
Debt
| Interest coverage ratio | n/a |
| Cash | US$92.50m |
| Equity | US$83.68m |
| Total liabilities | US$15.73m |
| Total assets | US$99.41m |
Recent financial health updates
We're Keeping An Eye On Jasper Therapeutics' (NASDAQ:JSPR) Cash Burn Rate
Aug 30
We Think Jasper Therapeutics (NASDAQ:JSPR) Needs To Drive Business Growth Carefully
Jan 23Companies Like Jasper Therapeutics (NASDAQ:JSPR) Are In A Position To Invest In Growth
Jul 31We're Keeping An Eye On Jasper Therapeutics' (NASDAQ:JSPR) Cash Burn Rate
Feb 02Recent updates
Jasper Therapeutics: Briquilimab's Potential In Chronic Urticaria And Asthma
Nov 18We're Keeping An Eye On Jasper Therapeutics' (NASDAQ:JSPR) Cash Burn Rate
Aug 30We Think Jasper Therapeutics (NASDAQ:JSPR) Needs To Drive Business Growth Carefully
Jan 23Companies Like Jasper Therapeutics (NASDAQ:JSPR) Are In A Position To Invest In Growth
Jul 31We're Keeping An Eye On Jasper Therapeutics' (NASDAQ:JSPR) Cash Burn Rate
Feb 02Jasper Therapeutics (NASDAQ:JSPR) Will Have To Spend Its Cash Wisely
Oct 14Jasper Therapeutics GAAP EPS of -$0.29 beats by $0.02
Aug 12Is Jasper Therapeutics (NASDAQ:JSPR) In A Good Position To Invest In Growth?
Jun 19Jasper Therapeutics: Advancing Cures With HSC Transplants And Safer Prior Conditioning
Nov 28We Think Jasper Therapeutics (NASDAQ:JSPR) Can Afford To Drive Business Growth
Nov 23Financial Position Analysis
Short Term Liabilities: JSPR's short term assets ($94.8M) exceed its short term liabilities ($12.5M).
Long Term Liabilities: JSPR's short term assets ($94.8M) exceed its long term liabilities ($3.3M).
Debt to Equity History and Analysis
Debt Level: JSPR is debt free.
Reducing Debt: JSPR has not had any debt for past 5 years.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: JSPR has sufficient cash runway for more than a year based on its current free cash flow.
Forecast Cash Runway: JSPR has sufficient cash runway for 1.1 years if free cash flow continues to reduce at historical rates of 27.6% each year.